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Abstract 
Background: The medical literature suggests that patients and physicians are deficient in their ability to use a self-
injectable epinephrine device (EpiPen®) for management of anaphylaxis. This study aims to determine whether a 
computer module is an effective tool for the instruction of a technical skill to medical trainees. 
Methods: We conducted a two group comparison study of 35 Post-Graduate Year 1 and 2 Family Medicine 
residents. Participants were instructed on use of the EpiPen® using either a written module or a computer module. 
Participants were evaluated on use of the EpiPen® using standardized objective outcome measures by a blinded 
assessor. Assessments took place prior to and following instruction, using the assigned learning modality. 
Results: There were 34 participants who completed the study. Both groups demonstrated significant improvement 
in demonstrating use of the EpiPen® following training (p < 0.001 for both). A significant post-training difference 
favouring the computer module learners over the written module learners was observed (p < 0.05). However, only 
53% and 18% of candidates (computer module and written module, respectively) were able to correctly perform 
all of the checklist steps. 
Conclusion: While our findings suggest computer modules represent an effective modality for teaching use of the 
EpiPen® to medical trainees, the low number of candidates who were able to perform all the checklist items 
regardless of modality needs to be addressed. 
 Correspondence: Dr. Kevin Fung, Victoria Hospital, Room A2-500, Zone A, Level 2, 800 Commissioners Road East, London, Ontario, Canada, N6A 5W9.  
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Introduction 
Anaphylaxis is an acute onset, and potentially fatal, 
systemic reaction requiring immediate medical 
intervention. Since the majority of anaphylactic 
reactions occur in the absence of medical 
professionals, self-injectable epinephrine devices 
(e.g. EpiPen®) are the first-line treatment in these 
situations.1,2 Accordingly, an EpiPen® is often 
prescribed for patients at risk for future anaphylactic 
episodes. 
It has been demonstrated that patients, their 
families, and health care professionals are deficient 
in their knowledge and comfort in using the 
EpiPen®.3,4,5 In one study of 68 patients prescribed 
an EpiPen®, only 29% employed it in a recurrent 
anaphylactic episode.6 A cross-sectional study 
demonstrated that parents’ comfort with the use of 
the EpiPen® correlated with previous administration 
of the device, previous EpiPen® training, and the 
feeling of a sense of empowerment in its use.7 In 
another study of 101 families of children prescribed 
an EpiPen®, 86% of families reported that they carry 
it “at all times”; however, it was found that only 55% 
had unexpired devices with them at that time. 
Furthermore, only 32% of were able to demonstrate 
correct use of the device.5 
The lack of comfort and familiarity may be due in 
part to poor patient instruction. A recent cross-
sectional study found that of 45 physicians who had 
previously prescribed an EpiPen®, 49% reported that 
they had not given education in any form to their 
patients and only 7% reported that they 
demonstrated use of the device.8 
The lack of patient instruction may be the result of 
physicians lack of expertise in regards to the 
EpiPen®. In a study of 100 residents and consultants, 
only 2 were able to demonstrate all six steps without 
first reading the instructions. Of the 95 physicians 
who read the instructions, only 39 correctly 
demonstrated the remaining 5 steps. The most 
concerning finding was that only 63% of the 
demonstrations would have resulted in adequate 
administration of epinephrine to the patient.8 
Due to improved technology and the widespread use 
of the internet, computer assisted learning is capable 
of providing medical professionals an opportunity to 
learn technical skills at their own pace.9 Learning is 
not restricted geographically, and can be extended 
to remote areas and developing countries.10,11 
Computer modules are capable of conveying visual 
and spatial components of technical skills.12,13  
The objective of the present study was to evaluate 
the use of computer modules in teaching a technical 
skill using resources that are currently available to 
physicians. Specifically, this study compared a 
computer-based learning module to traditional 
reading materials in teaching medical residents the 
use of the EpiPen® for management of an 
anaphylactic episode. 
Methods and Materials 
Two instructional modalities were employed to 
compare a computer module in teaching the use of 
the EpiPen® to traditional reading materials. Both 
the computer module and the written module were 
obtained from the manufacturer of the EpiPen® and 
are currently available to all physicians (King 
Pharmaceuticals, Bristol, Tennessee). A trainer 
EpiPen® (issued by the same manufacturer) that 
contains neither a needle nor epinephrine was used 
for demonstrations. Ethics approval was obtained via 
the University of Western Ontario Research Ethics 
Board (UWO REB# 15904E). 
Participants 
All post-graduate year 1 (PGY-1) and post-graduate 
year 2 (PGY-2) Family Medicine residents at the 
Schulich School of Medicine & Dentistry, University 
of Western Ontario, were invited to participate in 
this study on a voluntary basis. Thirty-five residents 
agreed to participate. 
Intervention 
Participants were randomly assigned to receive 
instruction regarding use of the EpiPen® via either a 
computer module or a written module. Prior to 
assignments, all participants were asked to complete 
questionnaires which covered both demographic 
information and previous training, use, and level of 
comfort with the EpiPen® (Table 1). 
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Table 1: Baseline Characteristics of Study Participants 
Characteristics Computer 
Module 
  (n=17) 
Written 
Module 
  (n=18) 
Demographics 
Age (years) a 31.06 (6.74) 30.44 (5.19) 
Male : Female 7:10 4:14 
PGY-1 : PGY-2 14:3 13:5 
Average Computer Usage (hours/week) >10 >10 
Pre-Intervention Questionnaire b 
Previously trained to manage anaphylaxis 7 (41%) 10 (56%) 
Previously trained to use an EpiPen® 3 (18%) 5 (28%) 
Previously taught someone to use an EpiPen® 1 (6%) 0 (0%) 
Previously experienced anaphylaxis themselves 0 (0%) 1 (6%) 
Previously encountered someone experiencing anaphylaxis 2 (12%) 5 (28%) 
Previously used an EpiPen® 0 (0%) 0 (0%) 
Comfortable using an EpiPen® c 2.25 (1.99) 2.69 (2.23) 
Comfortable teaching use of an EpiPen® c 2.5 (2.56) 1.94 (2.42) 
Pre-Test Results d 
Recognized pen   8 (47%) 10 (56%) 
Removed grey cap 10 (59%) 9 (50%) 
Selected outer mid-thigh as injection site 14 (82%) 11 (61%) 
Black end injected 7 (41%) 9 (50%) 
Adequate pressure to activate device 2 (12%) 1 (6%) 
Hold in place for >5 seconds 0 (0%) 0 (0%) 
Overall score (/6) 2.41 2.22 
Total time elapsed (seconds) a 19.84 (11.09) 18.19 (9.30) 
a Data reported as No. (Standard Deviation)  
b Indicates participants who selected a ‘yes’ answer 
c Scored on a Visual Analogue Scale of 0 (low) – 10 (high) (Standard Deviation) 
d Indicates participants who performed the step correctly, except for the “Overall Score”, which is the sum of all 
parameters in the pre-test (maximum score is 6). 
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Before receiving any instruction, all participants 
completed a pre-test evaluation to establish their 
baseline skill. Participants were asked to 
demonstrate use of the EpiPen® on themselves as 
they felt was necessary for management of 
anaphylaxis. Participants were not permitted to ask 
questions.  
Participants were then provided their learning 
modules in a quiet study area without any time 
constraints. The written module was a concise one-
page document demonstrating appropriate use of 
the EpiPen® using text, graphics, and photographs. It 
specifically demonstrates removing the cap, 
selecting the mid-outer thigh as the injection site, 
using the black end to inject, applying adequate 
pressure and holding it in place. These represent five 
of the six points that participants were evaluated on 
during their demonstrations (see Outcomes ). All of 
these points are included in text, and some are 
supplemented with images.  
The computer module group was provided a 
computer preloaded with the web-based module. 
The computer module demonstrated the 
appropriate use of the EpiPen® via a real-time video 
demonstration, along with verbal instructions from 
the presenter. Participants could forward and rewind 
the computer module as necessary. Like the written 
module, the computer module specifically 
demonstrated the five competencies mentioned 
above.  Neither module referenced the 6-step scale 
that was used as the primary outcome measure (see 
Outcomes); this scale is largely a research tool.  
The written module and computer module were the 
same as what is currently available to physicians 
from the manufacturer without any modifications. 
We were unable to obtain permission from the 
manufacturer to reproduce the modules; both are 
freely available to physicians and the public directly 
from the manufacturer: King Pharmaceuticals, 
Bristol, Tennessee. 
After the intervention, all participants were asked to 
once again demonstrate use of the EpiPen® as a 
post-test. Finally, participants were asked to 
complete a post-intervention questionnaire that 
inquired about their respective module, and their 
post-test performance. 
Procedures 
Participants were randomly assigned to either the 
written module group or computer module group. 
Allocation concealment was ensured by use of 
sealed opaque envelopes. All participants’ 
demonstrations were assessed at pre- and post-test 
by one assessor. The assessor (ASR) was blind to 
participants’ group allocation.  
Outcome Measures 
For both pre-test and post-test, the time taken to 
demonstrate use of the EpiPen® was measured in a 
standardized manner: time started when the 
participant first picked up the EpiPen® and stopped 
when the participant put it down or announced their 
completion.  
Objective outcome measures: All demonstrations 
were assessed by one author (ASR) on a 6-point scale 
previously published in the EpiPen® literature8  
(Table 2).  
Table 2: 6-point EpiPen® Demonstration Checklist 
1 point Recognized pen 
1 point Removed grey cap 
1 point Selected outer mid-thigh  
as injection site 
1 point Black end injected 
1 point Adequate pressure to activate device 
1 point Hold in place for >5 seconds 
 
Recognition of the EpiPen® was deemed complete if 
the participants were able to orient themselves to 
the EpiPen® within 5 seconds; pressure to activate 
the device was deemed adequate once the device 
made a ‘clicking’ sound, as it is designed to do; the 
time that the participant held the device in place was 
measured with a stopwatch. The items on the 6-pt 
scale were evaluated as either complete or 
incomplete.  
The primary outcome measure was the total score 
on the 6-pt scale for demonstration of the EpiPen®. 
The secondary outcome measures included the pre-
intervention and post-intervention questionnaires as 
well as the total time elapsed for the demonstration 
during both the pre- and post-learning tests. 
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Sample size  
A priori sample size calculations were performed to 
determine the number of participants needed to 
detect effect sizes. We expected a difference of at 
least 1 point on the 6-pt scale, which we considered 
to represent an educationally and clinically 
significant improvement. A sample size of 16 
participants per group was identified as necessary to 
achieve 80% power with a two-sided significance 
level of .05, assuming an equivalent standard 
deviation of 1 in both groups. 
Statistical analysis 
Paired t-tests were used to compare the pre-
intervention and post-intervention demonstration 
scores of participants from both the computer and 
written module groups. Paired t-tests were also used 
to compare the pre-intervention and post-
intervention total time elapsed for demonstration 
for both intervention groups. Two-sample t-tests 
were used to compare the total change in score and 
total change in time elapsed for demonstration. 
Two-sample t-tests were used to compare the 
number of participants correctly performing each 
step on the 6-pt demonstration scale. 
Results 
Of the 163 post-graduate year 1 and post-graduate 
year 2 Family Medicine residents at the University of 
Western Ontario, 35 agreed to participate. Of those 
included in the study, 17 were randomly assigned to 
the computer module group, and 18 to the written 
module group. One participant from the written 
module group subsequently withdrew from the 
study. 
Participants in both groups were similar for age, sex, 
level of academic training, and previous training and 
comfort in regard to both anaphylaxis and the 
EpiPen®.  The pre-intervention questionnaire 
revealed that only about half of all participants had 
previously learned how to manage anaphylaxis; of 
note, only a quarter of respondents had previously 
received training in use of the EpiPen®. Pre-test 
results demonstrated equal performance across 
both groups. No participant was able to demonstrate 
all 6 steps correctly (Table 1). Similar equivalence 
was observed between groups when evaluating 
specific items in the 6-point checklist.  Overall scores 
and total time elapsed were also comparable 
between the two groups. 
Both educational groups demonstrated significant 
improvement from pre-test to post-test as 
evidenced by EpiPen® demonstrations (p < 0.001 for 
both) (Table 3). Of note, when comparing the change 
in score from pre-test to post-test, the computer 
module group demonstrated a statistically significant 
improvement in score compared to the written 
module group (p < 0.05). Both groups also 
demonstrated improvements in total time elapsed 
for their demonstrations; the computer module 
group demonstrated a statistically significant faster 
time during the post-test demonstration than the 
written module group (p < 0.01) (Table 4). The 
computer module group scored significantly higher 
in post-test scores in steps 5 and 6, which are the 
final steps in the delivery of epinephrine 
intramuscularly into the patient or demonstrator. 
Both groups performed particularly poorly, however, 
in the final step, i.e. to hold the EpiPen® in place for 
5 seconds (53% for computer module, 18% for 
written module).  
The post-test questionnaire demonstrated that 
participants using both modules thought that they 
were well designed (Table 5). Without having seen 
the other intervention, all of the participants in the 
computer module group would choose the computer 
module if they had the choice; 71% of the written 
module group would choose the written module if 
given the choice.  This too reflects well on the design 
of both modules. 
Discussion 
The implications of this study are two-fold. First, it 
appears that many PGY-1 and PGY-2 Family Medicine 
residents have not been taught use of the EpiPen® in 
their medical school or residency curricula. Second, 
computer modules provide a viable vehicle for 
continuing medical education, especially as it relates 
to a technical skill. 
Self-injectable epinephrine devices such as the 
EpiPen® have become a mainstay of treatment for 
patients at risk of an anaphylactic episode. 
Unfortunately,  many patients  are  uncomfortable in  
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Table 3: Comparing Pre-Test to Post-Test Performance (Scores and Elapsed Time) 
Modules Pre-Test Mean Total Score (/6) Post-Test Mean Total Score (/6) p-value 
Computer Module 2.41 5.41 < 0.001 
Written Module  2.22 4.35 < 0.001 
 Pre-Test Mean Elapsed Time (s) Post-Test Mean Elapsed Time (s) p-value 
Computer Module 19.84 10.83 < 0.01 
Written Module 18.19 15.45 ns 
 
 
Table 4: Post-test Results of Study Participants  
Post-test Resultsa Computer Module 
(n=17) 
Written Module 
(n=17) 
p-value 
Recognized pen 17 17  
Removed grey cap 17 16 0.324 
Selected outer mid-thigh as injection site 17 15 0.153 
Black end injected 17 16 0.324 
Adequate pressure to activate device 15 8 0.009* 
Hold in place for >5s 9 3 0.031* 
Overall Score (/6) 5.41 4.35 <0.001* 
Change in Overall Score +3 +2.13 0.035* 
Total Time Elapsed (seconds) b 10.83 (2.67) 15.45 (4.87) 0.0017* 
a Indicates participants who performed the step correctly, except for the “Overall Score”, which is the sum of all parameters in 
the pre-test (maximum score is 6). 
b Data reported as No. (Standard Deviation)  
 
 
Table 5: Secondary Endpoints: Post-intervention Questionnairea 
Questionnaire Items Computer Module 
(n=17) 
Written Module 
(n=17) 
p-value 
1. How did the module improve your understanding 
of administering an EpiPen®? 
8.91 (1.66) 7.93 (2.23) 0.154 
2. How useful is the module format for teaching skills 
to physicians? 
8.19 (1.87) 7.76 (1.89) 0.516 
3. How comfortable are you with administering an 
EpiPen® for management of anaphylaxis? 
8.71 (1.95) 8.15 (2.17) 0.435 
4. How comfortable are you with teaching the use of 
EpiPen® for management of anaphylaxis? 
7.87 (2.31) 8.10 (2.26) 0.772 
5. How likely are you to use the module to teach your 
patients about the use of an EpiPen®? 
8.76 (1.65) 8.60 (1.53) 0.773 
6. If given option of how to learn, would you choose 
the module to which you were randomized? 
17 (100.0%) 12 (71%)  
a Scored on a Visual Analogue Scale of 0 (low) – 10 (high) (Standard Deviation) 
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regard to their ability to use the EpiPen®, and most 
do not use it when the need arises.5 When patients 
do use the EpiPen®, they may employ the device 
incorrectly and we cannot be assured that they 
received a therapeutic dose of epinephrine. A 
surprisingly common complication of EpiPen® use is 
digital ischemia: there is a series of case reports in 
which the patient held the EpiPen® in an inverted 
manner and injected the epinephrine into a finger, 
creating a second emergency.15,16,17,18 
Physicians frequently fail to instruct their patients on 
use of the EpiPen®. It is likely that physicians’ lack of 
familiarity with the device is contributing to the lack 
of patient instruction.8 Computer modules provide a 
potential vector for teaching technical skills to 
physicians.  
Current medical literature is ambiguous in regard to 
the effectiveness of computer modules as a teaching 
tool: knowledge and skill retention rates have 
demonstrated no difference in some studies 
comparing didactic teaching to computer modules, 
and others have favoured one modality over the 
other.9 However, much of the literature is focused 
on acquisition of conceptual knowledge while the 
current study focuses on acquisition of a 
psychomotor skill. A previous study involving 
medical students found computer modules to be 
superior to written modules in the teaching of nose 
packing for epistaxis management.9  
Previous studies have demonstrated that patients, 
their families, residents, and attending physicians 
lack familiarity with use of the EpiPen®.5,8 As 
expected, the low pre-test performance of 
participants from both groups in our study 
confirmed the lack of training (Table 1). This 
demonstrates that use of the EpiPen® is not entirely 
intuitive and requires at least some level of training 
for effective and safe use. 
In this study, participants from both groups 
demonstrated statistically significant improvements 
in performance on the post-test with training. 
Additionally, there was a statistically significant post-
test difference favouring the computer module 
group over the written module group (Table 2). This 
leads to the suggestion that the computer module 
group was able to learn the skill more effectively 
than their written module counterparts. Since both 
modules were designed to cover the same content, 
it is unlikely that these differences can be attributed 
to content discrepancies. Participants in the 
computer module group were able to benefit from 
continuous audio-visual input as opposed to written 
text and static images. 
Additionally, unlike with written materials, real-time 
demonstrations are possible using computer 
modules. The computer module group had 
significantly better performance in the final two 
steps of the procedure compared to the written 
module group. The fifth step involved applying 
adequate pressure to activate the device; this was 
confirmed when a ‘clicking’ sound was made, and 
the sound was audible in the computer module. This 
step is limited by the fact that the study involves a 
trainer EpiPen®. Many participants seemed wary of 
the training device although they were informed at 
the start of the study that it did not contain a needle 
nor any medication. However, they were not 
permitted to ask questions during the 
demonstrations and this may have resulted in some 
participants in both groups applying less pressure 
and failing this step. It seems reasonable that many 
participants would apply more pressure in an 
emergency setting in order to provide an 
intramuscular injection but this would be difficult to 
evaluate.  
The final step in the checklist evaluation required the 
participant to hold the EpiPen in place for at least 
five seconds. The computer module group did 
perform better in this final step and it is possible that 
this group had a better appreciation of the time 
required to administer the epinephrine because they 
were able to see the demonstration in real-time. 
Performance across both groups was poor for this 
final step in the post-test demonstration (53% for 
computer module, 18% for written module). This 
suggests that future modules that involve a timed 
step should place greater emphasis upon this during 
the training. Medical trainees work in a busy 
environment and may have underestimated how 
long 5 seconds is or undervalued the significance of 
holding the device in place for 5 seconds. The latter 
point does have some merit: we chose an objective 
measure of 5 seconds that has been previously used 
Canadian Medical Education Journal 2011, 2(2) 
e80 
as a research tool; the clinical significance of holding 
the device in place for 5 seconds has not been 
established and an adequate dose may be possible 
with a shorter duration of injection.5,8 
The present study does have limitations, including 
the absence of a cross-over design. Furthermore, it 
compares only two possible learning modalities. 
Future studies should aim to explore didactic 
learning, small group seminars, and direct 
instruction from an expert. While this study 
demonstrates short-term skill acquisition, long-term 
skill retention is unknown. 
Conclusion 
Professional organizations have begun to adopt 
computer modules for medical education at all levels 
of training.9 This is beneficial for the trainees 
because they can access peer-reviewed modules 
produced by experts. Given the global reach of the 
internet, computer modules have the potential to 
provide medical professionals with improved access 
to medical training tools. Prior to implementation, 
modules must be studied empirically to ensure 
efficacy in skill acquisition.  
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